Markets:

Overview

News

Currencies

International

Treasuries

Royal Bank of Canada (NY:RY)

203.95 +1.79 (+0.89%)

Streaming Delayed Price Updated: 11:16 AM EDT, Jun 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Royal Bank of Canada

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

53 54 Next >

RBC Bearings (NYSE:RBC) Reports Sales Below Analyst Estimates In Q1 Earnings

May 16, 2025

Bearings manufacturer RBC Bearings (NYSE:RBC) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 5.8% year on year to $437.7 million. Next quarter’s revenue guidance of $429 million...

Via StockStory

RBC Bearings Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

May 16, 2025

Via Benzinga

What's Next: RBC Bearings's Earnings Preview ↗

May 15, 2025

Via Benzinga

RBC Bearings Earnings: What To Look For From RBC

May 15, 2025

Bearings manufacturer RBC Bearings (NYSE:RBC) will be announcing earnings results tomorrow before market open. Here’s what to expect.

Via StockStory

Owens Corning’s Board Clears 12M Share Repurchase Ahead Of Investor Day — Stock Unmoved Pre-Market ↗

May 14, 2025

The announcement follows a slew of price cuts from analysts after the company’s second-quarter outlook disappointed Wall Street.

Via Stocktwits

Topics World Trade

UnitedHealth Regains Retail Confidence Amid After-Hours Rebound: Analysts React To CEO Exit, FY25 Guidance Suspension ↗

May 13, 2025

At least two research firms said the stock may have bottomed following the “latest in a string of setbacks.”

Via Stocktwits

1 Mid-Cap Stock to Target This Week and 2 to Ignore

May 13, 2025

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...

Via StockStory

CurrencyNewsBreaks – Aegis Capital Corp. Serves as Sole Book-Running Manager for Super League Enterprise (NASDAQ: SLE) $869,999 Public Offering

May 12, 2025

Via Investor Brand Network

Topics Retirement

Digital Ad Firm Trade Desk Rebounds With Better-Than-Expected Earnings ↗

May 09, 2025

Trade Desk stock rose after the digital advertising firm rebounded with a better-than-expected Q1 after lowering expectations in early 2025.

Via Investor's Business Daily

Wall Street Remains Overwhelmingly Bullish About This 9.2%-Yielding Dividend Stock Despite Economic Uncertainty and Volatility ↗

May 09, 2025

Via The Motley Fool

Topics Economy Government World Trade

May 09, 2025

Via The Motley Fool

Topics Artificial Intelligence Government

$1000 Invested In RBC Bearings 15 Years Ago Would Be Worth This Much Today ↗

May 07, 2025

Via Benzinga

Palantir Stock Plummets As Analysts Flag Valuation Risks Despite Q1 Revenue Beat ↗

May 06, 2025

Analysts warn that while Palantir's execution is impressive, concerns remain that its stock trades at a valuation difficult to justify without further acceleration.

Via Stocktwits

Topics Artificial Intelligence Earnings Government

Neurocrine Biosciences Surges On 'Surprising' Momentum For Its Newest Drug ↗

May 06, 2025

The company reported a strong start for its newest drug, Crenessity, which treats a hormonal disorder involving the adrenal glands.

Via Investor's Business Daily

Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks ↗

May 06, 2025

The company paused a study of a cystic fibrosis treatment, right on the heels of a scrapped type 1 diabetes program.

Via Investor's Business Daily

Topics Government Intellectual Property

Analysts Still Like Chevron, Cite Strong FCF & Balance Sheet As Key Amid OPEC And Recession Fears ↗

May 05, 2025

B of A Securities analyst maintains Buy rating on Chevron Corp. despite mixed Q1 earnings. Reiterates attractive investment due to strong cash flow and financial position. RBC Capital Markets also...

Via Benzinga

Topics Economy

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Files Amended $700M Market Manipulation Complaint in Federal Court

May 05, 2025

Via Investor Brand Network

Diamondback Energy Q1 Preview: Investors Eyeing Production Forecast Amid Oil Price Drop, Retail’s Divided ↗

May 05, 2025

Wall Street expects the oil and gas producer to post adjusted earnings of $4.20 per share on revenue of $3.75 billion.

Via Stocktwits

Topics World Trade

2 Profitable Stocks with Promising Prospects and 1 to Brush Off

May 05, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Cybersecurity Stocks: Artificial Intelligence Dominates RSA Conference But Monetization Still In Question ↗

May 02, 2025

The RSA conference this week didn't deliver much breaking news on cybersecurity stocks but Wall Street analysts came away upbeat on industry trends.

Via Investor's Business Daily

Topics Artificial Intelligence

2 Cash-Producing Stocks with Competitive Advantages and 1 to Avoid

May 02, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

Price Over Earnings Overview: RBC Bearings ↗

May 01, 2025

Via Benzinga

Palantir's Government, Commercial Business Trends Eyed In Q1 Earnings ↗

May 01, 2025

Palantir reports Q1 earnings on Monday, the data analytics software maker's government and commercial businesses will again be in focus.

Via Investor's Business Daily

Topics Artificial Intelligence Earnings

Here's How Much $100 Invested In RBC Bearings 15 Years Ago Would Be Worth Today ↗

May 01, 2025

Via Benzinga

Visa's Q2 Results Reflect Steady US Spending Despite Market Uncertainty: Analyst Highlights Strength In Payment Volumes ↗

April 30, 2025

Visa gains after RBC's Perlin highlights strong Q2 results, steady U.S. spending, and a $30B buyback plan.

Via Benzinga

BridgeBio's Pfizer-Rivaling Heart Drug Just Obliterated Sales Expectations ↗

April 29, 2025

The company sells a rival to Pfizer' heart treatment, Vyndaqel. Sales smashed expectations in its first quarter on the market.

Via Investor's Business Daily

1 Industrials Stock to Consider Right Now and 2 to Approach with Caution

April 29, 2025

Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But they are at the whim of volatile macroeconomic factors that influence...

Via StockStory

Topics Stocks

DoorDash's Deliveroo Offer Seen As 'Meaningfully Expanding' Global Reach ↗

April 28, 2025

DoorDash stock analysts were mostly positive on the company's offer to acquire U.K.-focused food delivery firm Deliveroo.

Via Investor's Business Daily

CG Oncology Rockets On Its Johnson & Johnson-Rivaling Cancer Drug ↗

April 28, 2025

The companies are working on treatments for a form of bladder cancer.

Via Investor's Business Daily

Did Google Earnings Results Put Search Worries To Rest? Here's What Analysts Are Saying ↗

April 25, 2025

Google stock climbed on better-than-expected Q1 earnings and search ad revenue as management touted the new AI Overviews format.

Via Investor's Business Daily

Topics Artificial Intelligence

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

53 54 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.